RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Piletz to Enzyme Inhibitors

This is a "connection" page, showing publications John Piletz has written about Enzyme Inhibitors.
Connection Strength

0.175
  1. Piletz JE, Klenotich S, Lee KS, Zhu QL, Valente E, Collins MA, Jones V, Lee SN, Yangzheng F. Putative agmatinase inhibitor for hypoxic-ischemic new born brain damage. Neurotox Res. 2013 Aug; 24(2):176-90.
    View in: PubMed
    Score: 0.097
  2. Huang MJ, Regunathan S, Botta M, Lee K, McClendon E, Yi GB, Pedersen ML, Berkowitz DB, Wang G, Travagli M, Piletz JE. Structure-activity analysis of guanidine group in agmatine for brain agmatinase. Ann N Y Acad Sci. 2003 Dec; 1009:52-63.
    View in: PubMed
    Score: 0.052
  3. Dontenwill M, Piletz JE, Chen M, Baldwin J, Pascal G, Ronde P, Dupuy L, Greney H, Takeda K, Bousquetd P. IRAS is an anti-apoptotic protein. Ann N Y Acad Sci. 2003 Dec; 1009:400-12.
    View in: PubMed
    Score: 0.013
  4. Zhu MY, Piletz JE, Halaris A, Regunathan S. Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells. Cell Mol Neurobiol. 2003 Oct; 23(4-5):865-72.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support